Original from: 360DX

The US Food and Drug Administration this week granted separate Emergency Use Authorizations for over-the-counter SARS-CoV-2 antigen self-tests developed by Osang Healthcare.

Osang's OHC COVID-19 Antigen Self Test is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in self-collected or adult-collected anterior nasal swabs. 

About a year ago, South Korea-based Osang inked a US distribution deal for its GeneFinder COVID-19 Plus RealAmp Kit with Todos Medical.

Source: Osang Healthcare Get FDA Emergency Use Authorization for COVID-19 Antigen Test